Reimagining Care and Research for Amyotrophic Lateral Sclerosis.
- Published in:
- 2025
- By:
- Publication type:
- Opinion
Works by SHARFSTEIN, JOSHUA
Results: 153
1
2
Drug Shortages—A Study in Complexity.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
3
Neurology and the Affordable Care Act.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 6, p. 623, doi. 10.1001/jamaneurol.2015.0083
- By:
- Publication type:
- Article
4
Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program-Reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter
5
Additional Barriers to Methadone Use in Hospitals and Skilled Nursing Facilities-Reply.
- Published in:
- 2020
- By:
- Publication type:
- journal article
6
Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration: A Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
7
Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities.
- Published in:
- 2020
- By:
- Publication type:
- journal article
8
Maryland's All-Payer Health Reform-A Promising Work in Progress.
- Published in:
- 2018
- By:
- Publication type:
- journal article
9
The Adequacy of Individual Hospital Data to Identify High Utilizers and Assess Community Health.
- Published in:
- 2016
- By:
- Publication type:
- journal article
10
Promise and Peril for Generic Drugs.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
11
An Update on Maryland's All-Payer Approach to Reforming the Delivery of Health Care.
- Published in:
- JAMA Internal Medicine, 2015, v. 175, n. 7, p. 1083, doi. 10.1001/jamainternmed.2015.1616
- By:
- Publication type:
- Article
12
Improving medical device regulation: a work in progress.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
13
Improving Medical Device Regulation.
- Published in:
- JAMA Internal Medicine, 2014, v. 174, n. 11, p. 1779, doi. 10.1001/jamainternmed.2014.3211
- By:
- Publication type:
- Article
14
Reducing Branded Prescription Drug Prices: A Review of Policy Options.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 11, p. 1469, doi. 10.1002/phar.2013
- By:
- Publication type:
- Article
15
The Domestic Consequences of Defunding Global Health.
- Published in:
- 2025
- By:
- Publication type:
- Opinion
16
Recognizing and Strengthening the 4 Pillars of US Childhood Vaccine Policy.
- Published in:
- 2025
- By:
- Publication type:
- Opinion
17
Advancing a National Infrastructure for Clinical Trials.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
18
Unwinding Medicaid Eligibility: Lessons for Health Policy.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
19
Data on the US Economy—A Model for Health Data?
- Published in:
- 2024
- By:
- Publication type:
- Opinion
20
The Role for Policy in AI-Assisted Medical Diagnosis.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
21
US Suicide Rates and Impact of Major Disasters Over the Last Century.
- Published in:
- Primary Care Companion for CNS Disorders (2155-7772), 2022, v. 24, n. 2, p. e1, doi. 10.4088/PCC.21com03168
- By:
- Publication type:
- Article
22
The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
23
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
24
Science and the Trump Administration.
- Published in:
- 2017
- By:
- Publication type:
- journal article
25
Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration.
- Published in:
- 2017
- By:
- Publication type:
- journal article
26
Enhancing Transparency at the US Food and Drug Administration: Moving Beyond the 21st Century Cures Act.
- Published in:
- 2017
- By:
- Publication type:
- journal article
27
Vaccines and the Trump Administration.
- Published in:
- 2017
- By:
- Publication type:
- journal article
28
Pharmaceuticals and Public Health.
- Published in:
- 2016
- By:
- Publication type:
- journal article
29
Population Health Case Reports: From Clinic to Community.
- Published in:
- 2016
- By:
- Publication type:
- journal article
30
A Stronger Treatment System for Opioid Use Disorders.
- Published in:
- JAMA: Journal of the American Medical Association, 2016, v. 315, n. 20, p. 2165, doi. 10.1001/jama.2016.3674
- By:
- Publication type:
- Article
31
Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion: A Study Interrupted.
- Published in:
- 2016
- By:
- Publication type:
- commentary
32
Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion.
- Published in:
- JAMA: Journal of the American Medical Association, 2016, v. 315, n. 10, p. 984, doi. 10.1001/jama.2016.1461
- By:
- Publication type:
- Article
33
Role of the FDA in Affordability of Off-Patent Pharmaceuticals.
- Published in:
- 2016
- By:
- Publication type:
- journal article
34
The Promotion of Medical Products in the 21st Century: Off-label Marketing and First Amendment Concerns.
- Published in:
- 2015
- By:
- Publication type:
- journal article
35
State Leadership in Health Care Transformation.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
36
The Safety of Prescription Drugs.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
37
Unrest in Baltimore: The Role of Public Health.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
38
Using Health Care Data to Track and Improve Public Health.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 20, p. 2012, doi. 10.1001/jama.2015.4795
- By:
- Publication type:
- Article
39
Of Mouse and Measles.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 15, p. 1504, doi. 10.1001/jama.2015.1135
- By:
- Publication type:
- Article
40
Achieving Health Equity by Design.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
41
On Fear, Distrust, and Ebola.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 8, p. 784, doi. 10.1001/jama.2015.346
- By:
- Publication type:
- Article
42
FDA Regulation of Laboratory-Developed Diagnostic Tests.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
43
Health Care and Poverty.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 21, p. 2200, doi. 10.1001/jama.2014.14532
- By:
- Publication type:
- Article
44
Treatment for opioid use disorder--reply.
- Published in:
- 2014
- By:
- Publication type:
- commentary
45
Treatment for Opioid Use Disorder.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
46
Confronting the Stigma of Opioid Use Disorder- and Its Treatment.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
47
Critical issues in US health care: health care on the edge.
- Published in:
- 2013
- By:
- Publication type:
- commentary
48
Critical Issues in US Health Care.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 310, n. 18, p. 1945, doi. 10.1001/jama.2013.282124
- By:
- Publication type:
- Article
49
Maryland's Health Disparities Initiatives.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
50
Fungal meningitis from injection of contaminated steroids: a compounding problem.
- Published in:
- 2012
- By:
- Publication type:
- journal article